|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/57 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61P 41/00 | (2006.01) | ||
| A61P 9/10 | (2006.01) |
| (11) | Number of the document | 2380587 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11172880.4 |
| Date of filing the European patent application | 2006-12-19 | |
| (97) | Date of publication of the European application | 2011-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-25 |
| (46) | Date of publication of the claims translation | 2018-01-25 |
| (30) | Number | Date | Country code |
| 760944 P | 2006-01-23 | US | |
| 05112630 | 2005-12-21 | EP |
| (72) |
Mannesse, Maurice, NL
Nuijens, Johannes Henricus, NL
Pieper, Frank, NL
De Simoni, Maria Grazia, IT
Ziere, Gijsbertus Johannes, NL
|
| (73) |
Pharming Intellectual Property B.V.,
Darwinweg 24, 2333 CR Leiden,
NL
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | C1 inhibitoriaus naudojimas išeminio-reperfuzinio pažeidimo prevencijai |
| Use of C1 inhibitor for the prevention of ischemia-reperfusion injury |
| Payment date | Validity (years) | Amount | |
| 2024-12-03 | 19 | 347.00 EUR |
| 2025-12-19 |